Differentially expressed homologous genes reveal interspecies differences of Paragonimus proliferus based on transcriptome analysis
, , , , , , , , , , , y
05 ago 2020
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 05 ago 2020
Páginas: 196 - 210
Recibido: 08 nov 2019
Aceptado: 01 abr 2020
DOI: https://doi.org/10.2478/helm-2020-0029
Palabras clave
© 2020 S. H. Li, S. D. Li, H. J. Li, J. Y. Li, J. J. Xu, G. J. Chang, L. J. Yang, W. Q. Wang, Y. L. Zhang, Z. Q. Ma, S. M. He, W. L. Wang, H. L. Huang, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

Fig. 8
![Fifty-eight Gene Ontology (GO) terms (11 cellular components [CC], 21 biological processes [BP], and 26 molecular functions [MF]) enriched by core genes. Four BP (phosphate-containing compound metabolic process, organophosphate metabolic process, phosphorus metabolic process, and carbohydrate derivative metabolic process) and three MF (phosphotransferase activity/alcohol group as acceptor, kinase activity, and transferase activity/transferring phosphorus-containing groups) were significantly enriched at P < 0.05.](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/6471e875215d2f6c89db4b3a/j_helm-2020-0029_fig_008.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=AKIA6AP2G7AKOUXAVR44%2F20250928%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20250928T053121Z&X-Amz-Expires=3600&X-Amz-Signature=24e75637b3fc34c5acd0dc6311e4588e895357a8bb6942a3b96fbff3e8a68f34&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Top 13 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways significantly enriched by differentially expressed homologous genes (P < 0_05)_
Pathways | Involving genes | Pathway ID | Level 2 | |
---|---|---|---|---|
Bladder cancer | 8 | 0.006593 | ko05219 | Cancers: Specific types |
Melanoma | 9 | 0.02046 | ko05218 | Cancers: Specific types |
Thyroid cancer | 9 | 0.03693 | ko05216 | Cancers: Specific types |
Pyruvate metabolism | 20 | 0.03104 | ko00620 | Carbohydrate metabolism |
Bile secretion | 14 | 0.04864 | ko04976 | Digestive system |
Aldosterone-sodium reabsorption regulated | 12 | 0.002475 | ko04960 | Excretory system |
Primary immunodeficiency | 6 | 0.02711 | ko05340 | Immune diseases |
Terpenoid backbone biosynthesis | 10 | 0.03597 | ko00900 | Metabolism of terpenoids and polyketides |
DNA replication | 17 | 0.01765 | ko03030 | Replication and repair |
FoxO signaling pathway | 24 | 0.0109 | ko04068 | Signal transduction |
TGF-beta signaling pathway | 15 | 0.01839 | ko04350 | Signal transduction |
VEGF signaling pathway | 11 | 0.03018 | ko04370 | Signal transduction |
mTOR signaling pathway | 13 | 0.03336 | ko04150 | Signal transduction |
Annotation information for the 16 core genes_
Gene-ID | Database | Annotated ID | Description |
---|---|---|---|
TR11359|c0_g1 | KEGG | smm:Smp_137080 | multidrug resistance protein; K05658 ATP-binding cassette, subfamily B (MDR/TAP), member 1 [EC:3.6.3.44] |
TR12766|c0_g1 | KEGG | oas:101108295 | tubulin alpha-3 chain; K07374 tubulin alpha |
TR16634|c0_g1 | KEGG | smm:Smp_164960 | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K; K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153] |
TR17957|c0_g1 | KEGG | fab:101816860 | WASF2; WAS protein family, member 2; K05748 WAS protein family, member 2 |
TR89500|c0_g1 | KEGG | smm:Smp_159120 | family C48 unassigned peptidase (C48 family); K08596 sentrin-specific protease 7 [EC:3.4.22.68] |
TR10230|c0_g1 | NR | gi|358340450|dbj|GAA48338.1| | retrovirus-related Pol polyprotein from transposon opus [Clonorchis sinensis] |
TR11281|c0_g1 | NR | gi|358253292|dbj|GAA52762.1| | serine/threonine-protein phosphatase 2A regulatory subunit B′′ subunit alpha [Clonorchis sinensis] |
TR15039|c0_g2 | NR | gi|684389238|ref|XP_009169318.1| | hypothetical protein T265_05919 [Opisthorchis viverrini] >gi|663050934|gb|KER26939.1| hypothetical protein T265_05919 [Opisthorchis viverrini] |
TR18101|c0_g1 | NR | gi|684372571|ref|XP_009164145.1| | hypothetical protein T265_01791 [Opisthorchis viverrini] >gi|663056274|gb|KER32181.1| hypothetical protein T265_01791 [Opisthorchis viverrini] |
TR22019|c0_g1 | NR | gi|358337500|dbj|GAA32515.2| | cell wall protein Awa1p [Clonorchis sinensis] |
TR18820|c0_g1 | SwissProt | sp|Q64640|ADK_RAT | Adenosine kinase OS=Rattus norvegicus GN=Adk PE=1 SV=3 |
TR18976|c0_g1 | SwissProt | sp|Q9D6Z1|NOP56_MOUSE | Nucleolar protein 56 OS=Mus musculus GN=Nop56 PE=1 SV=2 |
TR20969|c0_g1 | SwissProt | sp|Q5EB30|ODF3A_XENTR | Outer dense fiber protein 3 OS=Xenopus tropicalis GN=odf3 PE=2 SV=1 |
TR21606|c0_g1 | SwissProt | sp|Q9P2D7|DYH1_HUMAN | Dynein heavy chain 1, axonemal OS=Homo sapiens GN=DNAH1 PE=2 SV=4 |
TR275|c0_g1 | SwissProt | sp|Q6DTY7|F264_MOUSE | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 OS=Mus musculus GN=Pfkfb4 PE=2 SV=4 |
TR50927|c0_g1 | SwissProt | sp|Q3UM45|PP1R7_MOUSE | Protein phosphatase 1 regulatory subunit 7 OS=Mus musculus GN=Ppp1r7 PE=1 SV=2 |
Top 28 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways significantly enriched by core genes (P < 0_05)_
Pathway | Pathway ID | Level 2 | Pvalue | Involving DEHGs |
---|---|---|---|---|
Choline metabolism in cancer | ko05231 | Cancers: Overview | 0.004227 | PI3K;WASF2 |
MicroRNAs in cancer | ko05206 | Cancers: Overview | 0.01585 | PI3K;MRP |
Melanoma | ko05218 | Cancers: Specific types | 0.02688 | PI3K |
Acute myeloid leukemia | ko05221 | Cancers: Specific types | 0.0292 | PI3K |
Non-small cell lung cancer | ko05223 | Cancers: Specific types | 0.03013 | PI3K |
Pancreatic cancer | ko05212 | Cancers: Specific types | 0.03338 | PI3K |
Endometrial cancer | ko05213 | Cancers: Specific types | 0.04168 | PI3K |
Chronic myeloid leukemia | ko05220 | Cancers: Specific types | 0.04397 | PI3K |
Colorectal cancer | ko05210 | Cancers: Specific types | 0.04718 | PI3K |
Fructose and mannose metabolism | ko00051 | Carbohydrate metabolism | 0.04352 | PFK-2/FBPase2 |
Apoptosis | ko04210 | Cell growth and death | 0.03661 | PI3K |
Carbohydrate digestion and absorption | ko04973 | Digestive system | 0.0292 | PI3K |
Type II diabetes mellitus | ko04930 | Endocrine and metabolic diseases | 0.02781 | PI3K |
Regulation of lipolysis in adipocytes | ko04923 | Endocrine system | 0.03292 | PI3K |
Thyroid hormone signaling pathway | ko04919 | Endocrine system | 0.03431 | PI3K;PFK-2/FBPase2 |
Prolactin signaling pathway | ko04917 | Endocrine system | 0.03754 | PI3K |
Aldosterone-regulated sodium reabsorption | ko04960 | Excretory system | 0.03013 | PI3K |
Fc gamma R-mediated phagocytosis | ko04666 | Immune system | 0.005578 | PI3K;WASF2 |
Toll-like receptor signaling pathway | ko04620 | Immune system | 0.02641 | PI3K |
Fc epsilon RI signaling pathway | ko04664 | Immune system | 0.03477 | PI3K |
B cell receptor signaling pathway | ko04662 | Immune system | 0.03754 | PI3K |
Bacterial invasion of epithelial cells | ko05100 | Infectious diseases: Bacterial | 0.02904 | PI3K;WASF2 |
Chagas disease (American trypanosomiasis) | ko05142 | Infectious diseases: Parasitic | 0.04214 | PI3K |
ABC transporters | ko02010 | Membrane transport | 0.0426 | MRP |
AMPK signaling pathway | ko04152 | Signal transduction | 0.007408 | PI3K;PFK-2/FBPase2 |
Jak-STAT signaling pathway | ko04630 | Signal transduction | 0.03615 | PI3K |
VEGF signaling pathway | ko04370 | Signal transduction | 0.03846 | PI3K |
mTOR signaling pathway | ko04150 | Signal transduction | 0.04901 | PI3K |